Skip to content
Indo Us Bio-Tech logo

Indo Us Bio-Tech

INDOUS NSE
₹66.69 +0.49 (+0.74%)
Market Cap
₹134 Cr
P/E
30.73
View as Markdown
MCP
Close 17 Nov 2026 ₹66.69 1Y −57.89 −46.5%
Start ₹124.58

Key Fundamentals

MicrocapConsumer GoodsFMCG

Price-based figures as of · EPS basis: Standalone · TTM

ROCE
14.50%
Debt to Equity
0.48
EPS (TTM)
₹2.17
Book Value
₹45.83
Market Cap
₹134 Cr
P/E (TTM)
30.73
P/B
1.46
ROE
15.30%
Dividend Yield
0.38%
EBITDA
₹6.90 Cr
52W High
₹159.00
52W Low
₹57.50
Day Range
₹65.87 – ₹67.99
Volume
1,832

Peer Comparison

Fast Moving Consumer Goods › Agricultural Food & other Products › Other Agricultural Products

Indo Us Bio-Tech peer comparison
420.1522.2214,5902.980.71%14.80%17.60%12,102656
412.9511.189,4521.521.04%11.70%15.20%6,226845
144.8513.046,6441.850.20%9.72%12.50%5,996510
713.5014.323,6701.810.69%15.00%15.80%1,304256
340.0512.742,9161.800.00%8.38%10.40%2,747232
238.5517.502,4602.490.00%15.80%15.70%2,624133
97.1137.061,9452.140.00%5.22%5.83%84349
Indo Us Bio-Tech (this company)
66.6930.731341.460.38%15.30%14.50%974
Median 8 companies289.3015.913,2931.830.29%13.25%14.85%2,686244

Comparable companies in the same industry. Market cap, P/E and P/B use the latest price; other metrics are as reported in filings. A dash means the figure is not published for that company.

Tapetide Score

Data-driven rating, 0–100, as of . How it works →

Overall score

39 Weak

Data confidence 100/100

Category scores

Quality
44
Weak
Returns, margins, earnings quality 22% weight
Valuation
31
Poor
Cheap vs sector & own history 24% weight
Growth
17
Poor
Sales & profit trajectory 9% weight
Financial Health
62
Good
Solvency, leverage, coverage 9% weight
Momentum
11
Poor
Trend strength, vol-adjusted 12% weight
Ownership
55
Average
FII/DII/promoter flows 24% weight

The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.

Key Insights

Strengths

1
  • Debtor days have improved from 64.6 to 45.5 days.

Weaknesses

2
  • Though the company is reporting repeated profits, it is not paying out dividend
  • Tax rate seems low

Technical Indicators

Technical signals: verdict and indicator counts
GroupSignalBearishNeutralBullish
OverallStrong Bearish1054
OscillatorsBullish153
Moving AveragesStrong Bearish901

Key readings

RSI (14)
45.07
Neutral
MACD (12,26,9)
−2.09
Bullish
SMA (50)
73.17
Bearish
SMA (200)
94.70
Bearish

As of

Growth Rate

From the financial statements below. 10Y, 5Y, 3Y: compound annual growth to Mar 2026; 1Y: fiscal year to Mar 2026 against Mar 2025; TTM: four quarters to Sep 2026 against Sep 2025.

Revenue

Revenue growth by window
10Y+19.23%
5Y+22.91%
3Y+21.99%
1Y+6.36%
TTM−18.30%

Net profit

Net profit growth by window
10Y+43.27%
5Y+20.80%
3Y+21.92%
1Y−19.36%
TTM−74.29%

Operating cash flow

Operating cash flow growth by window
10Y—
5YTurned negative
3YTurned negative
1YTurned negative
TTM—

10Y: The statements do not go back far enough for this window.

TTM: Reported once a year, so there is no trailing-twelve-month figure.

Operating margin· change in pp

Operating margin growth by window
10Y+12.77 pp
5Y+1.33 pp
3Y−0.03 pp
1Y−2.84 pp
TTM−7.64 pp

Revenue by year

Revenue by year, ₹ crore
Mar 2017₹24.26 Cr
Mar 2018₹29.40 Cr
Mar 2019₹35.35 Cr
Mar 2020₹39.76 Cr
Mar 2021₹39.37 Cr
Mar 2022₹49.38 Cr
Mar 2023₹60.84 Cr
Mar 2024₹72.84 Cr
Mar 2025₹104 Cr
Mar 2026₹110 Cr

Net profit by year

Net profit by year, ₹ crore
Mar 2017₹0.40 Cr
Mar 2018₹1.45 Cr
Mar 2019₹2.09 Cr
Mar 2020₹2.53 Cr
Mar 2021₹5.10 Cr
Mar 2022₹5.24 Cr
Mar 2023₹7.24 Cr
Mar 2024₹8.24 Cr
Mar 2025₹16.27 Cr
Mar 2026₹13.12 Cr

Quarterly Results

₹ Cr
INDOUS quarterly results, ₹ crore
Particulars Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Sales
15.81
22.11
15.77
24.72
22.17
23.56
33.38
30.77
30.85
22.8
26.02
32.99
15.05
Expenses
13.21
17.88
14.79
21.03
17.05
18.02
28.8
25.3
26.69
18.65
22.79
29.02
17.66
Operating Profit
2.6
4.23
0.98
3.69
5.12
5.54
4.58
5.47
4.16
4.15
3.23
3.97
−2.61
OPM %
16.45%
19.13%
6.21%
14.93%
23.09%
23.51%
13.72%
17.78%
13.48%
18.2%
12.41%
12.03%
−17.34%
Other Income
0
0.08
0.21
0.03
0.02
0.02
0.12
0
0.03
0.01
0.02
0.12
0.05
Interest
0.41
0.37
0.36
0.33
0.52
0.38
0.26
0.45
0.42
0.77
0.6
0.74
0.81
Depreciation
0.21
0.19
0.2
0.2
0.18
0.16
0.56
0.2
0.21
0.22
0.27
0.27
0.28
PBT
1.98
3.75
0.63
3.19
4.45
5.02
3.88
4.82
3.56
3.17
2.38
3.08
−3.65
Tax %
15.66%
1.87%
17.46%
0.63%
2.03%
−0.8%
4.9%
2.49%
3.09%
5.36%
17.23%
1.3%
0.55%
Net Profit
1.67
3.68
0.52
3.17
4.36
5.05
3.68
4.7
3.45
3
1.97
3.04
−3.67
EPS (₹)
0.83
1.84
0.26
1.58
2.17
2.52
1.84
2.34
1.72
1.50
0.98
1.52
−1.83
YoY Sales growth
14.98
42.65
−12.92
29.15
40.23
6.56
112
24.47
39.15
−3.23
−22.05
7.21
−51.22

Profit & Loss

₹ Cr
INDOUS profit and loss, annual, ₹ crore
Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales
19.58
19.02
24.26
29.4
35.35
39.76
39.37
49.38
60.84
72.84
104
110
96.86
Expenses
18.98
18.52
23.02
26.69
31.91
35.78
33.83
42.43
51.45
62.05
84.9
93.43
88.12
Operating Profit
0.6
0.5
1.24
2.71
3.44
3.98
5.54
6.95
9.39
10.79
18.94
17.01
8.74
OPM %
3.06%
2.63%
5.11%
9.22%
9.73%
10.01%
14.07%
14.07%
15.43%
14.81%
18.24%
15.4%
9.02%
Other Income
0.09
0.1
0.07
0.22
0.03
−0.01
0.03
0.18
0.02
0.32
0.18
0.05
0.2
Interest
0.32
0.22
0.64
0.72
0.4
0.88
1.18
1.2
1.2
1.52
1.49
2.24
2.92
Depreciation
0.11
0.14
0.15
0.17
0.25
0.23
0.26
0.44
0.83
0.8
1.1
0.9
1.04
PBT
0.26
0.24
0.52
2.04
2.82
2.86
4.13
5.49
7.38
8.79
16.53
13.92
4.98
Tax %
−92.31%
−50%
25%
28.92%
25.53%
11.54%
−23.49%
4.55%
2.03%
6.37%
1.57%
5.75%
—
Net Profit
0.5
0.36
0.4
1.45
2.09
2.53
5.1
5.24
7.24
8.24
16.27
13.12
4.34
EPS (₹)
0.49
0.35
0.39
1.41
1.44
1.74
3.52
2.86
3.60
4.11
8.11
6.54
2.17
Div. Payout %
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
—
Sales growth
32.75
−2.86
27.55
21.19
20.24
12.48
−0.98
25.43
23.21
19.72
42.56
6.36
−18.3

Balance Sheet

₹ Cr
INDOUS balance sheet, annual, ₹ crore
Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Sep 2026
Equity Capital
1.49
1.49
1.49
3.42
4.85
6.07
6.07
9.17
10.03
20.05
20.05
20.05
20.05
Reserves
1.41
1.77
2
1.52
9.05
10.37
15.47
29.71
44.47
42.7
58.47
72.48
71.85
Borrowings
1.69
4.68
4.85
6.54
6.17
8.58
11.48
12.5
11.6
14.33
14.84
37.03
44.17
Other Liabilities
3.09
5.74
4.2
5.67
3.81
9.68
10.66
4.19
3.37
7.38
4.49
3.54
4.26
Total Liabilities
7.68
13.68
12.54
17.15
23.88
34.7
43.68
55.57
69.47
84.46
97.85
133
140
Fixed Assets
1.09
1.06
1.21
1.5
1.37
1.41
2.33
5.54
7.37
6.69
10.23
11.22
11.19
CWIP
0
0
0
0
1.17
1.28
1.99
2.32
1.37
3.78
0
0.5
1.03
Investments
0
0
0
0
0
0
0.01
0.01
0
0
0
0
0
Other Assets
6.59
12.62
11.33
15.65
21.34
32.01
39.35
47.7
60.73
73.99
87.62
121
128
Total Assets
7.68
13.68
12.54
17.15
23.88
34.7
43.68
55.57
69.47
84.46
97.85
133
140

Cash Flow

₹ Cr
INDOUS cash flow, annual, ₹ crore
Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
—
—
0.07
−0.88
−3.17
−0.84
0.22
2.91
0.53
2.22
1.42
−12.58
Investing
—
—
−0.17
0.31
−2.56
−0.57
−1.75
−5.4
−6.67
−2.53
−0.79
−1.5
Financing
—
—
0.05
0.59
5.74
1.53
1.46
2.41
6.29
1.22
−1.48
19.96
Net Cash Flow
—
—
−0.05
0.02
0.01
0.12
−0.07
−0.08
0.14
0.91
−0.85
5.88
Free Cash Flow
—
—
−0.1
−1.33
−4.46
−1.21
−1.68
−1.06
−1.29
−0.39
0.56
−14.99
CFO/EBITDA
—
—
11
−16
−92
−20
6
47
9
23
9
−71

Ratios

INDOUS financial ratios, annual
Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
24.61
107
76.13
112
93.55
193
229
152
148
95.46
52.73
45.48
Inventory Days
90.92
118
92.15
98.01
176
751
—
—
—
—
—
—
Days Payable
56.63
115
64.13
71.45
33.87
667
—
—
—
—
—
—
Cash Conversion Cycle
58.89
110
104
138
236
276
229
152
148
95.46
52.73
45.48
Working Capital Days
66.36
32.62
33.55
59.34
129
137
186
257
285
266
247
248
ROCE %
13.94%
7.34%
14.25%
27.85%
20.41%
16.68%
18.33%
15.85%
14.61%
14.4%
21.15%
14.5%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Indo Us Bio-Tech insights

60 extracted metrics across FY15–FY27.

Shareholding Pattern

As of Sep 2026

  • Promoters 68.29%
  • Public 24.47%
  • Others 6.98%
  • DIIs 0.25%
  • FIIs 0.01%

No promoter shares pledged as of 14 Oct 2026

Change since Jun 2026

Documents

Frequently Asked Questions about Indo Us Bio-Tech

What does Indo US Bio-Tech Ltd do?
Incorporated in 2004, Indo US Bio-Tech Ltd is engaged in production and processing of commercial and vegetable seeds
Where is Indo US Bio-Tech Ltd (INDOUS) listed?
Indo US Bio-Tech Ltd trades as INDOUS on the NSE and under code 541304 on the BSE.
Which sector does Indo US Bio-Tech Ltd belong to?
Indo US Bio-Tech Ltd is classified under the Fast Moving Consumer Goods sector, in the Agricultural Food & other Products industry.
What is the market capitalisation of Indo US Bio-Tech Ltd?
Indo US Bio-Tech Ltd has a market capitalisation of ₹133.73 Cr as of 17 Nov 2026, which places it in the Microcap band.
What is the PE ratio of Indo US Bio-Tech Ltd?
Indo US Bio-Tech Ltd trades at a PE ratio of 30.73 as of 17 Nov 2026, on earnings per share of ₹2.17, against a book value of ₹45.83 per share.
What is the 52-week high and low of Indo US Bio-Tech Ltd?
Over the last 52 weeks Indo US Bio-Tech Ltd has traded between ₹57.5 and ₹159 as of 17 Nov 2026.
Does Indo US Bio-Tech Ltd pay dividends?
Indo US Bio-Tech Ltd has a dividend yield of 0.38%.
What is the Return on Equity (ROE) of Indo US Bio-Tech Ltd?
Indo US Bio-Tech Ltd reported a return on equity of 15.30%. Its debt-to-equity ratio is 0.48.

Company Information

Incorporated in 2004, Indo US Bio-Tech Ltd is engaged in production and processing of commercial and vegetable seeds

CEO Mr. Jagdishkumar Devjibhai Ajudia
Listed 27 Sep 2024
Face Value ₹10
Shares Outstanding 2,00,52,000

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/INDOUS.md for Indo US Bio-Tech Ltd: dated key facts, then this page's sections in order: latest price, key fundamentals, peer comparison, the Tapetide Score, technical indicators, analyst ratings, growth rates, analyst forecasts, the AI analysis and news digest (labelled as AI-generated), financial statements, shareholding pattern, documents and the FAQ.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our Indian stock market MCP server.

Explore More